We are very pleased to announce that, Grace Yeh, our Chairman and CEO, has received a prestigious award from the Industrial Technology Research Institute (ITRI) in Taiwan for her lifetime achievement as a business leader. Under Grace’s leadership, Onivyde® was the first cancer drug developed in Taiwan to be approved by the US FDA in 2015.

Taiwan’s President Tsai Ing-wen presented the award personally to Grace, who is the first female business leader to become a laureate. 

 

More details on the ITRI website / on Focus Taiwan 

 

ITRI it is a not-profit R&D organization engaging in applied research and technical services. Founded in 1973, ITRI has played a vital role in transforming Taiwan's economy from a labor-intensive industry to a high-tech industry.